Barbara Ann Karmanos Cancer Institute - Test2 - elhamkhani - TriplyDB

Barbara Ann Karmanos Cancer Institute

Barbara Ann Karmanos Cancer Institute

http://www.wikidata.org/entity/Q4858714

Karmanos_Cancer_Institute %D9%85%D8%A4%D8%B3%D8%B3%D9%87_%D8%B3%D8%B1%D8%B7%D8%A7%D9%86_%D8%A8%D8%A7%D8%B1%D8%A8%D8%A7%D8%B1%D8%A7_%D8%A2%D9%86_%DA%A9%D8%A7%D8%B1%D9%85%D8%A7%D9%86%D9%88%D8%B3 Q4858714

about

sameAs

Melissa N Zimel Aliccia Bollig-Fischer Mohammad Muhsin Chisti Michael Simon Theresa Hastert Nerissa Therese Viola-Villegas Joshua Reineke Alexey L Glazyrin K-U Wagner Besa Xhabija Jhansi Rani Kalluri Mohamad Kabach Kristen S Purrington Simon S Lo

P108

McLaren Health Care Corporation

P355

Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma Sitravatinib and Nivolumab in Urothelial Carcinoma Study Study of XL281 in Adults With Solid Tumors Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By Surgery Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)A Study of RO5137382 (GC33) in Patients With Advanced or Metastatic Hepatocellular Carcinoma Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer Weight Loss Counseling for African American Women Who Are Breast Cancer Survivors A Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of TAK-981 in Adult Participants With Metastatic Solid Tumors or Lymphomas.Reducing Metabolic Syndrome Among Breast Cancer Survivors MyPatientPal: An App to Help Patients Manage Their Cancer Care Tobacco Cessation Intervention Vedolizumab in the Prophylaxis of Intestinal Acute Graft vs Host Disease in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer Brachytherapy in Treating Patients With Prostate Cancer Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome Pyrazoloacridine in Treating Women With Metastatic Breast Cancer Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma

P6153

Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer Weight Loss Counseling for African American Women Who Are Breast Cancer Survivors Reducing Metabolic Syndrome Among Breast Cancer Survivors Music in Reducing Distress in Participants With Cancer During Chemotherapy Treatment Tobacco Cessation Intervention Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer Pyrazoloacridine in Treating Women With Metastatic Breast Cancer Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer KRN5500 in Treating Patients With Metastatic Solid Tumors Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome Fenretinide in Treating Patients With Solid Tumors Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC)AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With Metastatic Well Differentiated Neuroendocrine Neoplasm Nivolumab and Radiation Therapy in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for Chemotherapy C.A.P.A.B.L.E. (CrossFit and Physical Activity: A Better Life Experience Study)Feasibility and Utilization of an Application-based Question Prompt List

P859

Q37385046-48082952-7DC8-4AB9-AD08-107F1E25DD42 Q37385945-CBEAF350-C59D-4EA4-BDC8-62E8A50FD2CC Q57003795-ADA2B1E1-7D83-4C69-A9FD-E6444146BFF4 Q57694652-393AE9D7-D593-4CA8-8989-0C1FC54A2E43 Q58149305-20E1F95F-BA96-44EB-B89C-FBFE1E994CC9 Q58313921-3FCE41E1-3276-44D8-8267-69C8E8810851 Q60057854-F0CDA8E0-2218-40DE-9AA0-0D88F6977059 Q73155777-80FB3FD4-AB0A-42EB-A32F-24B52EE8A1D7 Q82755803-89494744-1938-4B0D-986F-614533B55C2E Q83926245-1A4D1B15-319F-47B3-9AED-668BAE6C39A9 Q84157837-A63103FD-A11E-49FB-923D-D54762274EA7 Q84630497-F72D9DE6-2590-46C2-A42B-BC5976D860A2 Q86929920-552B17FE-0B52-4AA7-A704-3A29A1D07580 Q88587740-8496D218-D0DF-4F32-8065-5D99FC7643DD

P108

Q6802057-D5018A43-D60F-4BA7-B694-91E1D2AFDDF8

P355

Q58407402-A95F6077-E3A5-4BB8-9221-FB235BBF463B Q58407403-5AAE6754-E102-465B-B66F-762815502846 Q58407493-D9B86A70-3526-4622-BDB8-8E452D9279C6 Q58407512-7931BFEE-FF22-4C64-8548-5D434D0589BD Q58407574-C1FFCB8E-C50B-4CBE-B77C-1C3825F99F3A Q58848851-441FC0D4-C5CC-4919-9028-617B22F40336 Q61862160-33A8EF5F-2C6D-4928-80F4-4CB70274007A Q61907246-67E5EC19-5FD9-4590-9F0F-CCCCB9DA40D9 Q61920920-CC900324-A6F1-401C-B510-3FBEC54BF6E4 Q61921654-9B23395B-6237-43B1-B605-6725677EEAA8 Q61932952-8465C919-E8E6-4CFC-9877-A0DD15F40209 Q61933601-7E947D04-68A6-4459-864B-E54CF9605F53 Q61938678-EDAE63CF-47E2-4309-AAAE-071EDFAD0380 Q61955968-C4DC851A-E893-42A9-ADE0-47C2C91C50C4 Q61956389-97C68283-4DAB-443C-B67E-52C106602259 Q61956812-FD18979A-4074-44E6-8515-0E6D7DCBE87F Q61957238-548A83B2-5D6D-4B47-BDFF-542A29C00AD4 Q61966605-36D2E7B2-C801-4D38-A110-38DAC68E46B0 Q61978903-4D397152-D619-40DF-A21B-891EF80E4FF5 Q61979131-2EB590EA-90A8-4152-B5E7-3AE408F9AAC0 Q61980131-CEC5F5BA-D171-406E-AE31-BEBE3F787135 Q61980459-E457888B-5731-4EE8-A8B2-259713F47440 Q62025591-E587C403-A1F2-402E-B73F-403E257F435D Q62040093-C8C9D2D6-EB47-404A-998D-E3AEA518D643 Q62054692-CC00F456-78C5-44BE-8332-14490726EC2B Q62062613-9FAD9647-60B0-4AC1-AFA8-9D5292366D80 Q62062643-57C14CAD-BCDD-4E90-9C96-14E5F34284A3 Q62104965-FF707AF6-D8FE-4047-88CF-0689540ADD95 Q62105045-4984B888-4617-4B66-AFAB-9A4AD994AB9C Q62105317-21237543-546B-4928-8EBD-0E0917945448 Q62105617-8135A3CD-9448-4D4E-86A3-2CF33FCF5033 Q62106094-419CFD0A-F84E-448B-8757-F6D62C4CFB0B Q62109983-F73A31A3-5313-4C43-B86F-5A4047AB22FB Q62109993-E7378B89-34FA-46F8-AFDF-E081509A06B5 Q62109997-615DD77B-29F7-49B6-8B8A-28DAA061DE65 Q62110002-8EA3E4CA-F046-4EA2-8062-25F78338F919 Q62110010-B423CB58-E671-46EC-B60A-53732E947C1C Q62110034-BC8BDE40-5B47-4988-A6C0-E53E3909C40B Q62110040-F6C63F24-A51F-47E7-88AC-66052D2A846E Q62110090-606413E4-8FCA-4C83-BCEB-E38D81126BAB

P6153

Q61921654-D9E87074-FCD4-45DE-86FF-0B5B6EDC94D2 Q61933601-510B2B3D-77CD-4DEE-B474-FEED6FF5D33F Q61955968-A8C2E318-343F-4C23-97A0-579F94A2315D Q61978903-85AE7E5B-72F0-4C8C-BB09-A0CFEB7CEFE2 Q61980131-6CBB3D82-4050-42A5-AFD2-F95E781729C4 Q61980459-742BCF90-5599-4B89-9488-E53B6881C4A3 Q62040093-B83C8B90-3DE3-4061-9B06-977BE5FB723B Q62054738-1E388BEB-3130-4DEE-8092-BBF6904F0D75 Q62062613-B2FD467B-F350-4498-8E70-E1F58C9724E1 Q62109983-90C2F5B7-967C-42F3-AF1F-33C466EA88B8 Q62110002-6D55979D-47F8-4C4E-B4F0-92FE8F8D371A Q62110034-76BB4FBE-E83B-4A33-BFDC-9833AC576C53 Q62110258-D58C9663-14EB-48A2-91B9-44BD3708DFA6 Q62110334-FF39200F-07C8-4E7D-B2B3-E4F96D8A5A69 Q62110342-5C7BDFBE-5477-47F2-A653-B933AF884857 Q62110343-9DC5CBC6-1651-4587-A37B-CFA943634595 Q62110773-6AFF10DB-5EDE-4C6B-92A0-ED3A35C6925E Q62110937-6620EF66-377A-4A85-B1D5-922D0693A29C Q62111007-E24558D5-2DE0-46DA-AA19-C1D077A31F89 Q62111009-1EC87036-841F-45A3-9952-5324B8A20E98 Q62111029-B40B85AA-7796-4D10-8BD1-6C8EE9318949 Q63322197-1A043585-F252-46F2-8ABC-B8CBA9B9832A Q63322818-0FFFF13E-D6BD-4428-AF37-A1CFA41CED0D Q63400604-763B4F2D-AAA0-4472-9C0A-257AF4C97A4B Q63403151-B25D0B5B-67B1-4A21-AF9D-8624CFE3B626 Q63595489-1A9D6CF0-0CA8-44A4-ABCA-12007A03910F Q63596843-1443BB12-3292-4E4C-86F0-87B5A0EB5180

P859

Barbara Ann Karmanos Cancer Institute

http://www.wikidata.org/entity/Q4858714

description

Krankenhaus

@de

facility in Detroit, United States

@en

griya sakit

@jv

hospital d'Estaos Xuníos

@ast

rumah sakik

@min

rumah sakit di Amerika Serikat

@id

rumoh sakét

@ace

مستشفى

@ar

병원

@ko

name

Barbara Ann Karmanos Cancer Institute

@en

مؤسسه سرطان باربارا آن کارمانوس

@fa

卡馬諾斯癌症研究所

@zh

type

label

Barbara Ann Karmanos Cancer Institute

@en

مؤسسه سرطان باربارا آن کارمانوس

@fa

卡馬諾斯癌症研究所

@zh

altLabel

Karmanos Cancer Institute

@en

prefLabel

Barbara Ann Karmanos Cancer Institute

@en

مؤسسه سرطان باربارا آن کارمانوس

@fa

卡馬諾斯癌症研究所

@zh

P131

Q4858714-0A74974D-B39B-4996-8178-FB72AB6C2E46

P1416

Q4858714-401913BE-ADB7-440B-8C60-293D0687F110

P17

Q4858714-2a46c3d1-4661-5791-41ec-fab10ec4aa43

P213

Q4858714-E8668B33-D58E-491D-ADCD-23A59EA2F8EF

P2427

Q4858714-3FAA4F0D-3AB2-438D-95F1-9EE3ABAADEC1

P31

Q4858714-7D5016FE-CC7F-4006-A450-87763DB9FD99

Q4858714-F0BFB292-F6D3-4118-8378-275654F01B25

P3500

Q4858714-06545A86-54E7-4A55-953D-925915831E69

P571

Q4858714-1e364c49-45c4-b1d7-e703-659d9a216fd9

Q4858714-FBE3D6DA-21D9-4893-90A6-ED3817796FEF

P625

Q4858714-1C4B49B6-D466-4A84-837A-B8B2E562CC10

P6782

Q4858714-FC4D3F12-6636-42C6-85AA-6B97C5036BF0

P6801

Q4858714-A1A0F95C-9A94-451F-839B-94A4BC583E22

P749

Q4858714-F7F22357-3E8D-406E-B1F7-2B8D1B80C8F9

P856

Q4858714-0f8175bc-4227-23ca-9ab4-4902ca3c0d5d

Q4858714-B19A0ECF-AA78-4DEA-BE0C-8505B73048E8

P131

P1416

Wayne State University School of Medicine

P17

Ameeriga Ütisriigiq

P213

0000 0004 0396 4462

http://www.w3.org/2001/XMLSchema#string

P2427

grid.477517.7

http://www.w3.org/2001/XMLSchema#string

P31

Baláy-tambalan

P3500

2965

http://www.w3.org/2001/XMLSchema#string

P571

1943-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

1978-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P625

Point (-83.10061 42.357444)

http://www.opengis.net/ont/geosparql#wktLiteral

P6782

00ee40h97

http://www.w3.org/2001/XMLSchema#string

P6801

123

http://www.w3.org/2001/XMLSchema#decimal

P749

McLaren Health Care Corporation

P856

http://www.karmanos.org/

cancer-care.aspx